These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23105099)
1. A novel role of Krüppel-like factor 8 in DNA repair in breast cancer cells. Lu H; Hu L; Li T; Lahiri S; Shen C; Wason MS; Mukherjee D; Xie H; Yu L; Zhao J J Biol Chem; 2012 Dec; 287(52):43720-9. PubMed ID: 23105099 [TBL] [Abstract][Full Text] [Related]
2. Identification of poly (ADP-ribose) polymerase-1 (PARP-1) as a novel Kruppel-like factor 8-interacting and -regulating protein. Lu H; Wang X; Li T; Urvalek AM; Yu L; Li J; Zhu J; Lin Q; Peng X; Zhao J J Biol Chem; 2011 Jun; 286(23):20335-44. PubMed ID: 21518760 [TBL] [Abstract][Full Text] [Related]
3. Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis. Li T; Lu H; Shen C; Lahiri SK; Wason MS; Mukherjee D; Yu L; Zhao J Oncogene; 2014 Sep; 33(39):4746-55. PubMed ID: 24096480 [TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells. Zhang H; Sun L; Xiao X; Xie R; Liu C; Wang Y; Wei Y; Zhang H; Liu L Cancer Sci; 2014 Sep; 105(9):1109-15. PubMed ID: 25040744 [TBL] [Abstract][Full Text] [Related]
6. KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer. Lu H; Hu L; Yu L; Wang X; Urvalek AM; Li T; Shen C; Mukherjee D; Lahiri SK; Wason MS; Zhao J Oncogene; 2014 May; 33(22):2909-17. PubMed ID: 23812425 [TBL] [Abstract][Full Text] [Related]
7. The role of Kif4A in doxorubicin-induced apoptosis in breast cancer cells. Wang H; Lu C; Li Q; Xie J; Chen T; Tan Y; Wu C; Jiang J Mol Cells; 2014 Nov; 37(11):812-8. PubMed ID: 25377255 [TBL] [Abstract][Full Text] [Related]
8. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. Lee SA; Jung M J Biol Chem; 2007 May; 282(20):15271-83. PubMed ID: 17371872 [TBL] [Abstract][Full Text] [Related]
9. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Muñoz-Gámez JA; Martín-Oliva D; Aguilar-Quesada R; Cañuelo A; Nuñez MI; Valenzuela MT; Ruiz de Almodóvar JM; De Murcia G; Oliver FJ Biochem J; 2005 Feb; 386(Pt 1):119-25. PubMed ID: 15456408 [TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis. Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780 [TBL] [Abstract][Full Text] [Related]
11. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932 [TBL] [Abstract][Full Text] [Related]
12. Major contribution of the multidrug transporter P-glycoprotein to reduced susceptibility of poly(ADP-ribose) polymerase-1 knock-out cells to doxorubicin action. Wesierska-Gadek J J Cell Biochem; 2005 Aug; 95(5):1012-28. PubMed ID: 15861398 [TBL] [Abstract][Full Text] [Related]
13. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer. Li T; Lu H; Mukherjee D; Lahiri SK; Shen C; Yu L; Zhao J Oncotarget; 2015 Aug; 6(25):21428-42. PubMed ID: 26025929 [TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186 [TBL] [Abstract][Full Text] [Related]
15. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein. Wurzer G; Herceg Z; Wesierska-Gadek J Cancer Res; 2000 Aug; 60(15):4238-44. PubMed ID: 10945636 [TBL] [Abstract][Full Text] [Related]
16. Sumoylation delimits KLF8 transcriptional activity associated with the cell cycle regulation. Wei H; Wang X; Gan B; Urvalek AM; Melkoumian ZK; Guan JL; Zhao J J Biol Chem; 2006 Jun; 281(24):16664-71. PubMed ID: 16617055 [TBL] [Abstract][Full Text] [Related]
17. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. Zhang FL; Yang SY; Liao L; Zhang TM; Zhang YL; Hu SY; Deng L; Huang MY; Andriani L; Ma XY; Shao ZM; Li DQ Theranostics; 2023; 13(3):973-990. PubMed ID: 36793866 [No Abstract] [Full Text] [Related]
18. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481 [TBL] [Abstract][Full Text] [Related]
19. PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside. Turk AA; Wisinski KB Cancer; 2018 Jun; 124(12):2498-2506. PubMed ID: 29660759 [TBL] [Abstract][Full Text] [Related]
20. p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1. Cazzalini O; Donà F; Savio M; Tillhon M; Maccario C; Perucca P; Stivala LA; Scovassi AI; Prosperi E DNA Repair (Amst); 2010 Jun; 9(6):627-35. PubMed ID: 20303835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]